187 related articles for article (PubMed ID: 12137306)
1. Socio-demographic characteristics of postmenopausal estrogen users.
Strinić T; Buković D; Karelović D; Despot A; Buković N; Giudici E; Silovski H
Coll Antropol; 2002 Jun; 26(1):245-9. PubMed ID: 12137306
[TBL] [Abstract][Full Text] [Related]
2. Socio-demographic characteristics of women with endometrial carcinoma.
Strinić T; Buković D; Bilonić I; Hirs I; Despot A; Boćan A
Coll Antropol; 2003; 27 Suppl 1():55-9. PubMed ID: 12955892
[TBL] [Abstract][Full Text] [Related]
3. Understanding attitudes of older women toward hormone replacement therapy.
Phelan EA; Buist DS; Anderson LA; Newton KM; Delaney KM; LaCroix AZ
Prev Med; 2001 Jan; 32(1):49-56. PubMed ID: 11162326
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy in postmenopausal women: utilization of health care resources by new users.
Thorp JM; Gavin NI; Ohsfeldt RL
Am J Obstet Gynecol; 2001 Aug; 185(2):318-26. PubMed ID: 11518885
[TBL] [Abstract][Full Text] [Related]
5. Postmenopausal hormone therapy and migraine headache.
Misakian AL; Langer RD; Bensenor IM; Cook NR; Manson JE; Buring JE; Rexrode KM
J Womens Health (Larchmt); 2003 Dec; 12(10):1027-36. PubMed ID: 14709191
[TBL] [Abstract][Full Text] [Related]
6. Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population.
Kerlikowske K; Miglioretti DL; Ballard-Barbash R; Weaver DL; Buist DS; Barlow WE; Cutter G; Geller BM; Yankaskas B; Taplin SH; Carney PA
J Clin Oncol; 2003 Dec; 21(23):4314-21. PubMed ID: 14645420
[TBL] [Abstract][Full Text] [Related]
7. Life prevalence and determinants of hormone replacement therapy in women living in Porto, Portugal.
Lucas R; Barros H
Maturitas; 2007 Jul; 57(3):226-32. PubMed ID: 17293067
[TBL] [Abstract][Full Text] [Related]
8. Use of hormone replacement therapy by menopausal women in six family-practice teaching clinics in Israel.
Vinker S; Kaplan B; Yaphe J; Cohen O; Shumla V; Shapira G; Shofty I; Kitai E
Climacteric; 2003 Mar; 6(1):75-80. PubMed ID: 12725667
[TBL] [Abstract][Full Text] [Related]
9. Use of hormone replacement therapy in Italian women aged 50-70 years.
Manzoli L; Di Giovanni P; Del Duca L; De Aloysio D; Festi D; Capodicasa S; Monastra G; Romano F; Staniscia T
Maturitas; 2004 Nov; 49(3):241-51. PubMed ID: 15488353
[TBL] [Abstract][Full Text] [Related]
10. Incidence of dementia in long-term hormone users.
Petitti DB; Crooks VC; Chiu V; Buckwalter JG; Chui HC
Am J Epidemiol; 2008 Mar; 167(6):692-700. PubMed ID: 18218608
[TBL] [Abstract][Full Text] [Related]
11. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
Windler E; Zyriax BC; Eidenmüller B; Boeing H
Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
[TBL] [Abstract][Full Text] [Related]
12. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
Brinton RD
Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
[TBL] [Abstract][Full Text] [Related]
13. Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study.
Barrett-Connor E; Wehren LE; Siris ES; Miller P; Chen YT; Abbott TA; Berger ML; Santora AC; Sherwood LM
Menopause; 2003; 10(5):412-9. PubMed ID: 14501602
[TBL] [Abstract][Full Text] [Related]
14. Trends of determinants of hormone therapy use in Italian women attending menopause clinics, 1997-2003.
Parazzini F;
Menopause; 2008; 15(1):164-70. PubMed ID: 17581495
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular, anthropometric and neurocognitive features of healthy postmenopausal women: effects of hormone replacement therapy.
Magri F; Gabellieri E; Busconi L; Guazzoni V; Cravello L; Valdes V; Sorrentino AR; Chytiris S; Ferrari E
Life Sci; 2006 Apr; 78(22):2625-32. PubMed ID: 16376385
[TBL] [Abstract][Full Text] [Related]
16. Background factors influencing somatic and psychological symptoms in middle-age women with different hormonal status. A population-based study of Swedish women.
Li C; Borgfeldt C; Samsioe G; Lidfeldt J; Nerbrand C
Maturitas; 2005; 52(3-4):306-18. PubMed ID: 15967603
[TBL] [Abstract][Full Text] [Related]
17. Hormone therapy, lipoprotein subclasses, and coronary calcification: the Healthy Women Study.
Mackey RH; Kuller LH; Sutton-Tyrrell K; Evans RW; Holubkov R; Matthews KA
Arch Intern Med; 2005 Mar; 165(5):510-5. PubMed ID: 15767525
[TBL] [Abstract][Full Text] [Related]
18. Quality of life and psychological symptoms in Greek postmenopausal women: association with hormone therapy.
Koundi KL; Christodoulakos GE; Lambrinoudaki IV; Zervas IM; Spyropoulou A; Fexi P; Sakkas PN; Soldatos CR; Creatsas GC
Gynecol Endocrinol; 2006 Dec; 22(12):660-8. PubMed ID: 17162707
[TBL] [Abstract][Full Text] [Related]
19. Life prevalence of hormone replacement therapy and profile of users have not changed among women with self-reported menopause in the last two decades in Porto, Portugal.
Lucas R; Barros H
Climacteric; 2008 Feb; 11(1):26-31. PubMed ID: 18202962
[TBL] [Abstract][Full Text] [Related]
20. Hormone replacement therapy and health behavior in postmenopausal polio survivors.
Kalpakjian CZ; Riley BB; Quint EH; Tate DG
Maturitas; 2004 Aug; 48(4):398-410. PubMed ID: 15283932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
